NASDAQ: JSPR
Jasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?

Insider buying vs selling

Have Jasper Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when JSPR insiders and whales buy or sell their stock.

JSPR Shareholders

What type of owners hold Jasper Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roche Holding Ltd27.57%9,174,212$5.23MInsider
Qiming Us Healthcare Fund II LP25.60%8,519,648$4.86MInsider
Barney A. Richmond19.43%6,464,048$3.68MInsider
Kurt Von Emster16.98%5,649,733$3.22MInsider
Abingworth LLP16.92%5,628,558$3.21MInsider
Kenneth F. Clifford6.91%2,300,000$1.31MInsider
Amplitude Healthcare Holdings LLC6.91%2,300,000$1.31MInsider
Howard I. Hoffen6.91%2,300,000$1.31MInsider
Balaji Venkataraman6.91%2,300,000$1.31MInsider
Velan Capital Investment Management LP4.31%1,433,828$817.28kInsider

1 of 3

JSPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JSPR0.02%99.98%
PLRZ0.01%4.01%Net Selling
KAPA0.00%32.08%
GNTA0.00%0.27%
NEUP0.03%99.97%Net Buying

Jasper Therapeutics Stock Ownership FAQ

Who owns Jasper Therapeutics?

Jasper Therapeutics (NASDAQ: JSPR) is owned by 0.04% institutional shareholders, 148.11% Jasper Therapeutics insiders, and 0.00% retail investors. Roche Holding Ltd is the largest individual Jasper Therapeutics shareholder, owning 9.17M shares representing 27.57% of the company. Roche Holding Ltd's Jasper Therapeutics shares are currently valued at $5.23M.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.